Project Details
| Short title | ADG126-1001 |
|---|---|
| Acronym | ADG126-1001 |
| Status | Active |
| Effective start/end date | 25/05/22 → 26/05/27 |
CTU: A First-in-Human (FIH), Open-Label, Phase I Dose Escalation and Expansion Study of ADG126, ADG126 in Combination with Toripalimab, and ADG126 in Combination with ADG106 in Patients with Advanced/Metastatic Solid Tumors
- Park, John (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research